Taylor RN,Yu J,Torres PB,et al.Mechanistic and therapeutic implications of angiogenesis in endometriosis[J].Reprod Sci,2009,16(2):140-146.
[2]
Giannopoulos K,Schmitt M,Wlasiuk P,et al.The high frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia is diminished through treatment with thalidomide[J].Leukemia.,2008,22(1):222-224.
[3]
Yang Y,Ge JP,Zhou ZT.Effects of thalidomide on DMBA-induced oral carcinogenesis in hamster with respect to angiogenesis[J].J Oral Pathol Med,2009,38(5):455-462.
[4]
Yagyu T,Kobayashi H,Matsuzaki H,et al.Thalidomide inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in endometriotic stromal cells,possibly through suppression of nuclear factor-kappaB activation[J].J Clin Endocrinol Metab, 2005,90(5):3017-3021.
[5]
Machado DE,Abrao MS,Berardo PT,et al.Vascular density and distribution of vascular endothelial growth factor(VEGF)and its receptor VEGFR-2(Flk-1)are significantly higher in patients with deeply infiltrating endometriosis affecting the rectum[J].Fertil Steril, 2008,90(1):148-155.
[6]
Laschke MW,Menger MD.In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis[J].Hum Reprod Update, 2007,13(4):331-342.
[7]
Bourlev V,Volkov N,Pavlovitch S,et al.The relationship between microvessel density,proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions[J].Reproduction, 2006,132(3):501-509.
Scarpellini F,Sbracia M,Lecchini S,et al.Anti-angiogenesis treatment with thalidomide in endometriosis:A pilot study.In:58th Annual Meeting of the American-Society-for-Reproductive-Medicine[M].2002 Oct 12-17.Seattle,Washington:2002:O228(Abstract).
